BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23729020)

  • 21. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
    Gerry D; Lentsch EJ
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidisciplinary head and neck cancer clinic and adherence with speech pathology.
    Starmer H; Sanguineti G; Marur S; Gourin CG
    Laryngoscope; 2011 Oct; 121(10):2131-5. PubMed ID: 21826674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival outcomes for second primary head and neck cancer: a matched analysis.
    Bhattacharyya N; Nayak VK
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.
    Bonaparte JP; Hart R; Trites J; Taylor MS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):642-8. PubMed ID: 19128670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pneumonia on short-term outcomes and cost of care after head and neck cancer surgery.
    Semenov YR; Starmer HM; Gourin CG
    Laryngoscope; 2012 Sep; 122(9):1994-2004. PubMed ID: 22777881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
    Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer of unknown primary: does treatment modality make a difference?
    Balaker AE; Abemayor E; Elashoff D; St John MA
    Laryngoscope; 2012 Jun; 122(6):1279-82. PubMed ID: 22538837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
    Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
    Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of selective neck dissection in the treatment of the clinically positive neck.
    Patel RS; Clark JR; Gao K; O'Brien CJ
    Head Neck; 2008 Sep; 30(9):1231-6. PubMed ID: 18642289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
    Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
    Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional outcomes of chemoradiation in patients with head and neck cancer.
    Tulunay-Ugur OE; McClinton C; Young Z; Penagaricano JA; Maddox AM; Vural E
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):64-8. PubMed ID: 22951428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.